key: cord-0791084-3xgtfmmg authors: Sivakanthan, Sananthan; Pan, James; Kim, Louis; Ellenbogen, Richard; Saigal, Rajiv title: Economic Impact of COVID-19 on a High Volume Academic Neurosurgical Practice date: 2020-08-10 journal: World Neurosurg DOI: 10.1016/j.wneu.2020.08.028 sha: 251c2eb89b96d9272fd83a289d0e902e52950187 doc_id: 791084 cord_uid: 3xgtfmmg Abstract: Introduction Coronavirus-19 (COVID-19) is a novel disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that rapidly spread around the globe. The dramatic increase in the number of cases and deaths have placed tremendous strain on healthcare systems worldwide. As healthcare workers and society adjust to focus treatment and prevention of COVID-19, other facets of the healthcare enterprise are affected, particularly surgical volume and revenue. Objective The purpose of this study is to describe the financial impact of COVID-19 on an academic neurosurgery department. Methods A retrospective review of weekly average daily work relative value units (wRVU) was compared before and after COVID-19 in the fiscal year 2020. A comparative time period of the same months in the year prior was also included for review. We also review strategies for triaging neurosurgical disease as needing emergent, urgent, or routine operative treatment. Results Daily average wRVU after COVID-19 dropped significantly with losses in all weeks examined. Of the 7 weeks in the current post-COVID period the weekly daily average wRVU was 173 (range 128-363). The mean decline was 51.4% compared to the pre-COVID era. Both inpatient and outpatient revenue was affected. Conclusion COVID-19 had a profound detrimental effect on surgical productivity and revenue generation. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus first detected in Wuhan, China in 2019. The WHO declared a global pandemic in March 2020, and COVID-19 has resulted over 5.5 million cases and approximately 350,000 deaths worldwide as of May 25, 2020 1, 2 . The first reported case in the United States occurred on January 19, 2020 in the State of Washington. Washington state has seen 21349 cases and 1118 deaths as of April 29 3 . Recently published data from Seattle healthcare systems estimate that half of those with COVID-19 admitted to an ICU will die 4 . Recent epidemics and pandemics such as SARS, Swine Flu and Ebola have tested the capacity of healthcare systems worldwide 5 . Historically, the largest of these pandemics, such as the bubonic plague, smallpox, and the Spanish Flu took the lives of upwards of 300 million people combined 5 . In early 2020, the economic and financial impact of COVID-19 in the United States began to rapidly manifest itself as a complex phenomenon and encompassed every aspect of the American economy. In the healthcare industry, the virus induced a paradoxical increase in resource utilization, but decrease in productivity and revenue 6, 7 . The complete economic impact of COVID-19 on healthcare systems and the global economy will take time to fully evaluate. Early estimates from the Medical Group Management Association (MGMA) 8 suggest that 97% of practices in their 724 practice survey experienced a negative financial impact either directly or indirectly associated with the virus. Practices also reported an average of 55% decrease in revenue and a 60% decrease in patient volume since the beginning of the COVID-19 crisis 8 . To date, there has been no published literature on the financial impact of the COVID-19 virus on surgical productivity and revenue. This report summarizes our experiences at the at the University of Washington (UW) Department of Neurological Surgery, in one of the first healthcare systems to directly confront this pandemic in the United States. A retrospective review of our institutional case volume was conducted during the period of 12/29/19 to 5/1/20. The data included operative volume from the UW Medical Center and Harborview Medical Center, two of four entities comprising the UW Medicine hospital system (the others being Valley Medical Center and UW Northwest Hospital). The data was extracted J o u r n a l P r e -p r o o f from the billing records of our financial department. The total wRVUs were measured and work RVU variance was also calculated. The immediate Pre-COVID comparative period was defined as 1/1/2020-3/15/2020. The Post-COVID period where stringent limits on elective cases were imposed began on 3/16/2020. A review of the total monthly RVUs for March, April and May of 2019 was used for comparison. At our institution, COVID-19 operative restrictions involved limiting cases to the following: neurotrauma, acute stroke, subarachnoid hemorrhage, acutely worsening myelopathy, cauda equina and neuro-oncology ( Table 1 ). The breakdown between inpatient and outpatient services in terms of wRVUs was also examined. There was a total of 11 weeks in the pre-COVID period since the beginning of the 2020 fiscal year. The pre-COVID weekly daily average wRVU was 533.1, ranging from 474 to 582 (-11 to +10 %variance). Of the 7 weeks in the current post-COVID period the weekly daily average wRVU was 173 ranging from 363 to 128 (-31 to -76 %variance) ( Economists and public health personnel have produced models for studying economic impact of pandemics 9, 10 . Rapid changes in the delivery and costs of healthcare, public policy changes, and societal behavioral changes during a pandemic make modelling challenging. The financing of health care in the United States includes private health insurance and public funding through Medicare/Medicaid. In this system, a so-called "cost-shift hydraulic" exists in which one payor group (usually private health insurers) pay substantially higher prices to offset lower prices paid by another payor group (usually the government or out-of-pocket payers). During a large scale pandemic where there is a drop in the gross domestic product and increased unemployment, there is a shift from employment-based private financing to public healthcare and/or being uninsured 11 . In addition to the macroeconomics of public health, an understanding of the microeconomics of physician reimbursement and hospital finance is required 12, 13 . Physician reimbursement can be separated into three parts: coding for procedures, coding for diagnoses, and Centers for Medicare and Medicaid services (CMS) determination of reimbursement. of respondents. Interestingly only 29.9% of respondents endorsed using some form of telemedicine. While their article did not specify numerical losses they did say that 62.5% of respondents experienced significant financial burden. In our review, COVID-19 had a significant impact on our department's surgical productivity with total wRVU production decreased as much as 75%. The effect was immediate with the initial week after COVID-19 restrictions seeing reduction in both inpatient (29%) and outpatient (85%) wRVUs. The inpatient decline is, as predicted, linear as increasing restriction on elective surgical volume caused increasingly lower wRVUs. This also corresponded to a decrease in hospital occupancy from 98% to 68% within the first few weeks of the pandemic. The outpatient wRVU decline was seen in the months leading up to the operating room freeze however there was an increase in the second week. We believe the initial prelude to the sharper decline to be due to the effect of public fear in response to the local outbreak of the virus 22 with a subsequent increase in wRVU in the following week. On March 23 2020 Washington state faced the institution of a state-wide stay-at-home mandate 23 which again significantly decreased our outpatient productivity. This corresponded to the peak of inpatient COVID cases (Figure 3) . In response to this mandate, telemedicine was instituted. Our hospital system embraced the use of telehealth (both video and phone call) which likely mitigated outpatient losses (Figure 4 ). This study is limited in that is represents an incomplete assessment of the total financial impact of COVID-19, which will likely not be completely appreciable until many months after normal operations has resumed. Additionally while they are familiar and easy to understand, wRVUs represent just a component of the true costs and revenue in a healthcare system. In this preliminary analysis COVID-19 had a significant detrimental impact on surgical volume and revenue generation with up to 76% loss of wRVU with a mean weekly wRVU loss of 51%. This effect was seen in both inpatient and outpatient care with up to 79% loss of inpatient wRVU and up to 83% loss of outpatient wRVU. This data however is not complete as follow-up studies in time are needed to fully elucidate the full financial effect of the virus. Table 1 : UW Medicine guidelines for the acuity and management of neurosurgical disease. J o u r n a l P r e -p r o o f IMHE COVID-19 Projections Covid-19 in Critically Ill Patients in the Seattle Region -Case Series COVID-19 Hits Some Health Care Workers With Pay Cuts and Layoffs Furlloughs and Pay Cuts in Advance of COVID-19 Surge COVID-19 Financial Impact on Medical Practices The economic impact of pandemic influenza in the United States: priorities for intervention Forecasting COVID-19 impact on hospital bed-days, ICU-days, ventilator-days and deaths by US state in the next 4 months Financial effects of an influenza pandemic on US hospitals. J Health Care Finance Physician coding and reimbursement Diagnosis-related Groups and Hospital Inpatient Federal Reimbursement COVID-19: Recommendations for Management of Elective Surgical Procedures Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology The Coronavirus Disease 2019 Global Pandemic: A Neurosurgical Treatment Algorithm. Neurosurgery. 2020 COVID-19 and spinal surgery The Impact of the Coronavirus (COVID-19) Pandemic on Neurosurgeons Worldwide. Neurosurgery. 2020 Coronavirus in Washington state: A timeline of the outbreak through J o u r n a l P r e -p r o o f